Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LOEWS CORPL · Entity 3231 | DIRECTOR EMERITUS | June 30, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LOEWS CORP
Report date June 30, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,165 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 102 · Balance 22,165 F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CANTEL MEDICAL CORP
Report date June 02, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-02 transaction · row 1
1 source rowRow 1 · 2021-06-02 · Disposition to issuer · Disposed 2,865,637 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy wife | 0 |
Reported balance
After 2021-06-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-06-02 · Disposition to issuer · Disposed 374,112 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy custodial accounts for benefit of grandchildren | 0 |
Reported balance
After 2021-06-02 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-06-02 · Disposition to issuer · Disposed 185,928 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectShares held by Dico Group, Inc. | 0 |
Reported balance
After 2021-06-02 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-06-02 · Disposition to issuer · Disposed 29,430 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration").
F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2019 Filed Jun 4, 2019 19:17 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $27.21 | $0.00 |
DisclosureSEC source: 0001567619-19-012660 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 19:17 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 706 | $51.71 | $36,507.26 |
DisclosureSEC source: 0001567619-19-012660 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,637 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $51.40 and $51.71. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 19:17 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 794 | $51.40 | $40,811.60 |
DisclosureSEC source: 0001567619-19-012660 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,343 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 19:17 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $27.21 | $40,815.00 |
DisclosureSEC source: 0001567619-19-012660 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2019 Filed May 14, 2019 20:31 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010837 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,979 Underlying: Common Stock · 1,979 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (each, an "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on May 14, 2020. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F2 · derivative.expiration_date: The RSUs vest on May 14, 2020. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 08, 2019 Filed May 9, 2019 13:31 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010202 · doc1.xml · derivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,959 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with 7 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F3 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with 7 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 08, 2019 Filed May 9, 2019 13:31 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010202 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:56 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $21.74 | $0.00 |
DisclosureSEC source: 0001567619-19-005983 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:56 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 820 | $47.81 | $39,204.20 |
DisclosureSEC source: 0001567619-19-005983 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,678 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $47.81 and $47.89. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:56 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 680 | $47.89 | $32,565.20 |
DisclosureSEC source: 0001567619-19-005983 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,498 Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:56 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $21.74 | $32,610.00 |
DisclosureSEC source: 0001567619-19-005983 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2018 Filed Jan 10, 2019 15:12 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | OtherCommon Stock, par value $.10 per share | 2,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-19-000001 · edgar.xml · nonDerivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By trust for benefit of children Disclosed balance after: 0 F1 · kind: Shares were transferred by Trust to a beneficiary of the Trust. Read SEC document |
| December 27, 2018 Filed Jan 10, 2019 15:12 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-19-000001 · edgar.xml · nonDerivative · entry 5 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By custodial accounts for benefit of grandchildren Disclosed balance after: 88,134 Read SEC document |
| December 27, 2018 Filed Jan 10, 2019 15:12 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-19-000001 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 450,188 Read SEC document |
| December 27, 2018 Filed Jan 10, 2019 15:12 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-19-000001 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,014,490 Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:25 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-007907 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959.6 Underlying: Common Stock · 2.7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 21:22 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $27.11 | $0.00 |
DisclosureSEC source: 0001567619-18-007332 · doc1.xml · derivative · entry 5 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 21:22 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 664 | $48.48 | $32,190.72 |
DisclosureSEC source: 0001567619-18-007332 · doc1.xml · nonDerivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,678 F2 · price: Represents the weighted average price of multiple transactions with a range of prices between $48.47 and $48.59. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 21:22 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 836 | $48.59 | $40,621.24 |
DisclosureSEC source: 0001567619-18-007332 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,342 Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 21:22 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $27.11 | $40,665.00 |
DisclosureSEC source: 0001567619-18-007332 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2018 Filed Jan 10, 2019 15:12 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | OtherCommon Stock, par value $.10 per share | 106,162 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-19-000001 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By trust for benefit of children Disclosed balance after: 2,109 F1 · kind: Shares were transferred by Trust to a beneficiary of the Trust. Read SEC document |
| October 18, 2018 Filed Oct 19, 2018 16:21 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 585 | $87.27 | $51,052.95 |
DisclosureSEC source: 0000019446-18-000061 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,016,540 F1 · shares: This represents shares withheld for taxes attributable to the vesting of time-based Restricted Stock Awards that vested on 10/18/18. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 15:59 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 340 | $88.42 | $30,062.80 |
DisclosureSEC source: 0000019446-18-000053 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017,125 F3 · shares: This represents shares withheld for taxes attributable to the vesting of (i) time-based RSUs that vested on 10/10/18 and (ii) performance-based RSUs that vested on 10/10/18. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 15:59 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par value $.10 per share | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-18-000053 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017,465 F2 · shares: This represents a performance-based RSU granted on 10/10/17, as adjusted based on the Company's sales performance during the fiscal year ended July 31, 2018. One-third of these RSUs (as adjusted) vested on 10/10/18 and the balance of these RSUs are now time-based, vesting in two equal annual installments on 10/10/19 and 10/10/20. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 15:59 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par value $.10 per share | 990 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-18-000053 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,016,858 F1 · shares: This represents time-based Restricted Stock Units (RSUs) granted on 10/10/18 that vest in three equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 15:31 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Exercise / conversionCommon Stock, par value $.10 per share · Derivative | 30,000 | $0.00 Strike: $31.81 | $0.00 |
DisclosureSEC source: 0000019446-18-000051 · edgar.xml · derivative · entry 8 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.10 per share · 30,000 shares Expires 2018-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 15:31 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 8,768 | $91.39 | $801,307.52 |
DisclosureSEC source: 0000019446-18-000051 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,015,868 Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 15:31 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 10,442 | $91.39 | $954,294.38 |
DisclosureSEC source: 0000019446-18-000051 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,024,636 Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 15:31 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Exercise / conversionCommon Stock, par value $.10 per share | 30,000 | $111.79 | $3,353,721.00 |
DisclosureSEC source: 0000019446-18-000051 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,035,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 14:52 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.4 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-002504 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,956.9 Underlying: Common Stock · 2.4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 20:57 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $38.38 | $0.00 |
DisclosureSEC source: 0001567619-18-002149 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 20:57 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 357 | $50.02 | $17,857.14 |
DisclosureSEC source: 0001567619-18-002149 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,675 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $50.01 and $50.34. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 20:57 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,143 | $50.34 | $57,538.62 |
DisclosureSEC source: 0001567619-18-002149 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,032 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 20:57 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $38.38 | $57,570.00 |
DisclosureSEC source: 0001567619-18-002149 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 20:21 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-028404 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,954.5 Underlying: Common Stock · 2.5 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| June 12, 2018 Filed Dec 4, 2018 21:22 UTC | LOEWS CORP L · Entity 3231 | OtherCommon Stock | 2.56 | $50.02 | $128.05 |
DisclosureSEC source: 0001567619-18-007332 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,678 F1 · kind: The Reporting Person's purchase of 2.56 shares of Common Stock reported herein, which resulted from an erroneous broker enrollment of the Reporting Person in an automatic dividend reinvestment program, was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's previously and timely reported sales of 2.56 shares of Common Stock at a price of $50.34 per share on September 4, 2018. The Reporting Person has agreed to pay to the Issuer $0.82, representing the full amount of the profit realized in connection with the short-swing transaction. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:17 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $47.71 | $0.00 |
DisclosureSEC source: 0001140361-18-027072 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:17 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 52 | $49.04 | $2,550.08 |
DisclosureSEC source: 0001140361-18-027072 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,675 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $48.97 and $49.39. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:17 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,448 | $49.39 | $71,516.72 |
DisclosureSEC source: 0001140361-18-027072 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,727 Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:17 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $47.71 | $71,565.00 |
DisclosureSEC source: 0001140361-18-027072 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2018 Filed May 9, 2018 20:26 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 2,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022504 · doc1.xml · derivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,141 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 9, 2017, the Reporting Person was granted 2,131 RSUs, which, together with 10 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F4 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 9, 2017, the Reporting Person was granted 2,131 RSUs, which, together with 10 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 09, 2018 Filed May 9, 2018 20:26 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022504 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| May 08, 2018 Filed May 9, 2018 20:26 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022504 · doc1.xml · derivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,952 Underlying: Common Stock · 1,952 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 8, 2019, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 8, 2019, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| March 29, 2018 Filed Mar 29, 2018 16:49 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 5,070 | $111.79 | $566,778.85 |
DisclosureSEC source: 0000019446-18-000018 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,005,078 F3 · price: The per share prices ranged from $111.0009 to $113.5050. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 16:49 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 4,246 | $110.68 | $469,929.02 |
DisclosureSEC source: 0000019446-18-000018 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010,148 F2 · price: The per share prices ranged from $110.00 to $111.50. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 16:49 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 2,584 | $113.15 | $292,374.69 |
DisclosureSEC source: 0000019446-18-000018 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,014,394 F1 · price: The per share prices ranged from $112.44 to $114.00. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2018 Filed Mar 13, 2018 16:45 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 9,500 | $115.49 | $1,097,144.55 |
DisclosureSEC source: 0000019446-18-000016 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,016,978 F3 · price: The per share prices ranged from $115.00 to $116.75. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:23 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.6 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-013632 · doc1.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,141.9 Underlying: Common Stock · 2.6 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 16:45 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 9,000 | $117.10 | $1,053,876.60 |
DisclosureSEC source: 0000019446-18-000016 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,026,478 F2 · price: The per share prices ranged from $116.15 to $118.73. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 16:45 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 1,500 | $119.11 | $178,662.45 |
DisclosureSEC source: 0000019446-18-000016 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,035,478 F1 · price: The per share prices ranged from $116.25 to $120.25. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.